Intravenous Contrast Computed Tomography Versus Native Computed Tomography in Patients With Acute Abdomen and Impaired Renal Function

NCT ID: NCT04196244

Last Updated: 2021-02-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

994 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-18

Study Completion Date

2033-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Computer tomography (CT) is the primary imaging option for acute abdominal pain in adults. Intravenous (IV) contrast media is used to improve the CT quality. In patients with impaired renal function, post-contrast acute kidney injury (PC-AKI) has remained a significant concern. Modern retrospective studies have shown no association between worsened baseline renal function and IV-contrast CT. However, no randomised controlled trial has been done to conclude this. The INCARO (INtravenous Contrast computed tomography versus native computed tomography in patients with acute Abdomen and impaired Renal functiOn) trial is a multicentre, open-label, parallel group, superiority, individually randomised controlled trial comparing IV-contrast enhanced CT to native CT in patients with impaired renal function. Patients requiring emergency abdominal or body CT with eGFR 15-45 ml/min/1.73 m2 are included in the study. The primary outcome is a composite outcome of all-cause mortality or renal replacement therapy within 90 days from CT.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Abdomen Radiocontrast Nephropathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Abdominal or body CT with intravenous contrast

Abdominal or body CT with intravenous contrast

Group Type EXPERIMENTAL

Abdominal or body CT with intravenous contrast

Intervention Type DIAGNOSTIC_TEST

Abdominal or body CT with intravenous contrast

Abdominal or body CT without intravenous contrast (native CT)

Abdominal or body CT without intravenous contrast (native CT)

Group Type ACTIVE_COMPARATOR

Abdominal or body CT without intravenous contrast (native CT)

Intervention Type DIAGNOSTIC_TEST

Abdominal or body CT without intravenous contrast (native CT)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Abdominal or body CT with intravenous contrast

Abdominal or body CT with intravenous contrast

Intervention Type DIAGNOSTIC_TEST

Abdominal or body CT without intravenous contrast (native CT)

Abdominal or body CT without intravenous contrast (native CT)

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients requiring emergency abdominal or body CT with eGFR 15-45 ml/min/1.73 m2

Exclusion Criteria

* Age less than 18 years
* Pregnancy
* eGFR less than 15 or more than 45 ml/min/1.73 m2
* Renal replacement therapy within 30 days prior enrolment
* CT with IV contrast less than 72 hours prior enrolment
* Suspicion of vascular occlusion, dissection or bleeding (i.e. need for IV-contrast)
* CT needed without IV-contrast to detect or rule out ureteral stone
* IV contrast allergy
* Inability to give written consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Helsinki University Central Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ville Sallinen

Adj. Prof., Consultant, Clinical researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jorvi hospital, Helsinki University Hospital

Espoo, , Finland

Site Status RECRUITING

Meilahti hospital, Helsinki University Hospital

Helsinki, , Finland

Site Status RECRUITING

Hyvinkää hospital

Hyvinkää, , Finland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Finland

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hanna Lampela, MD, PhD

Role: primary

+35894711

Ville Sallinen, MD, PhD

Role: primary

+35894711

Taina Nykänen, MD, PhD

Role: primary

+35894711

References

Explore related publications, articles, or registry entries linked to this study.

Raty P, Mentula P, Lampela H, Nykanen T, Helantera I, Haapio M, Lehtimaki T, Skrifvars MB, Vaara ST, Leppaniemi A, Sallinen V. INtravenous Contrast computed tomography versus native computed tomography in patients with acute Abdomen and impaired Renal functiOn (INCARO): a multicentre, open-label, randomised controlled trial - study protocol. BMJ Open. 2020 Oct 6;10(10):e037928. doi: 10.1136/bmjopen-2020-037928.

Reference Type DERIVED
PMID: 33028554 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

INCARO-HYKS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MR Urography vs CT Urography
NCT02606513 COMPLETED NA
Study About Contrast Media
NCT05678023 RECRUITING NA